Merck & Co., Inc. (NYSE:MRK) Q1 2023 Earnings Conference Call April 27, 2023 9:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Robert Davis - Chairman and CEO Caroline Litchfield - Chief Financial Officer Dr. Dean Li - President, Merck Research Labs Conference Call Participants Seamus Fernandez - Guggenheim Luisa Hector - Berenberg Chris Shibutani - Goldman Sachs Hardik Parikh - JPMorgan Carter Gould - Barclays Timothy Anderson - Wolfe Research Andrew Baum - Citigroup Mar ...

As filed with the Securities and Exchange Commission on February 24, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 _________________________________ FORM 10-K (MARK ONE) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 1-6571 Merck & Co., Inc. 126 Ea ...

Merck & Co., Inc. (NYSE:MRK) Q4 2022 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Rob Davis - Chairman and CEO Caroline Litchfield - Chief Financial Officer Dr. Dean Li - President, Merck Research Labs Conference Call Participants Carter Gould - Barclays Andrew Baum - Citi Evan Seigerman - BMO Louise Chen - Cantor Tim Anderson - Wolfe Research Geoff Meacham - Bank of America Mohit Bansal - Wells Fargo Chris Schott - JPMorgan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities Registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.50 par value) MRK New York Stock Exchange 0.500% Notes due 2024 MRK 24 New York Stock Exchange 1.875% Notes due 2026 MRK/26 New York Stock Exchange 2.500% Notes due 2034 MRK/34 New York Stock Exchange 1.375% Notes due 2036 MRK 36A New York Stock Exchange FORM 10-Q (Mark One) ☒ QUART ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities Registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.50 par value) MRK New York Stock Exchange 0.500% Notes due 2024 MRK 24 New York Stock Exchange 1.875% Notes due 2026 MRK/26 New York Stock Exchange 2.500% Notes due 2034 MRK/34 New York Stock Exchange 1.375% Notes due 2036 MRK 36A New York Stock Exchange FORM 10-Q (Mark One) ☒ QUART ...

Merck & Co, Inc. (NYSE:MRK) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Peter Dannenbaum - VP, IR Robert Davis - President, CEO & Director Caroline Litchfield - EVP & CFO Dean Li - EVP & President;, Merck Research Laboratories Conference Call Participants Evan Seigerman - BMO Capital Markets Andrew Baum - Citigroup Louise Chen - Cantor Fitzgerald & Co. Carter Gould - Barclays Bank Seamus Fernandez - Guggenheim Securities Geoffrey Meacham - Bank of America Merrill Lynch Ume ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities Registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.50 par value) MRK New York Stock Exchange 0.500% Notes due 2024 MRK 24 New York Stock Exchange 1.875% Notes due 2026 MRK/26 New York Stock Exchange 2.500% Notes due 2034 MRK/34 New York Stock Exchange 1.375% Notes due 2036 MRK 36A New York Stock Exchange FORM 10-Q (Mark One) ☒ QUART ...

Good morning. My name is Grace Lacra and I'll be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co Q1 sales and earnings conference call. All lines have been placed on mute to prevent any background noise. And after the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star then the number one on your telephone keypad. And to withdraw your question, please press the pound key. Than ...

As filed with the Securities and Exchange Commission on February 25, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 _________________________________ FORM 10-K (MARK ONE) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 1-6571 ________________________ ...